Skip to main content
ConductScienceScienceDex

Herbert Wanjala Kavunja

NIH Rank #26400
Unclaimed recordClaim profile
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 12040598Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2026 onlyCareer claims are limited to the years shown.

NIH Funding · FY2026

Linked Award Amount
$300K
Full award amounts, FY2026
Award Records
1
Records listing this PI
Award-Linked Rank
#26,400
By linked amount among FY2026 PIs
Earliest Year Loaded
2026
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Herbert Wanjala Kavunja. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award data coverage

ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.

Single fiscal year on record (FY2026): $300K in linked award amounts across 1 award record · Award-linked rank #26400.

FY2026 award records by amount

NIH award records listing Herbert Wanjala Kavunja as a PI. Multi-PI records show the full award amount for context.

  • 1R43AI197624-01R43
    Next generation multi-antigen Staphylococcus aureus vaccine enabled by proprietary mutant bacteriophage Qbeta
    Iaso Therapeutics, Inc.
    $300K
    award amount

Award organization

Organizations that administered FY2026 awards listing Herbert Wanjala Kavunja as a PI.

FY2026 award administered by Iaso Therapeutics, Inc. (MI).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2026
    First NIH Award
    Iaso Therapeutics, Inc.

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Herbert Wanjala Kavunja.

Rachel Leigh Moszyk
Iaso Therapeutics, Inc.
1
shared award

Explore further

Find collaborators for Herbert Wanjala Kavunja

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →